Cargando…

G-Proteins Agonists and NO/cGMP Blockers: Unexplored Frontiers in the Pharmaceutical Industry

Detalles Bibliográficos
Autor principal:	Evora, Paulo Roberto B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Cardiologia - SBC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5644205/ https://www.ncbi.nlm.nih.gov/pubmed/29069206 http://dx.doi.org/10.5935/abc.20170139

Ejemplares similares

Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? “Reasons That Reason Itself Does Not Know...”
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

Blocking soluble guanylate cyclase could be the present and future of NO/cGMP inhibition for vasoplegia treatment
por: Barbosa Evora, Paulo Roberto
Publicado: (2018)

Neutron Diffraction Reveals Hydrogen Bonds Critical for cGMP-Selective Activation: Insights for cGMP-Dependent Protein Kinase Agonist Design
por: Huang, Gilbert Y., et al.
Publicado: (2014)

NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

Effects of NO/cGMP inhibitors in a rat model of anaphylactoid shock
por: Albuquerque, A.A.S., et al.
Publicado: (2020)

Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)

Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum
Publicado: (1984)

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
por: Mullershausen, Florian, et al.
Publicado: (2003)

PDE5 says NO to cGMP
por: LeBrasseur, Nicole
Publicado: (2003)

cGMP steers axons home
por: LeBrasseur, Nicole
Publicado: (2002)

A novel pathway of cGMP
por: Kuhn, Michaela, et al.
Publicado: (2011)

The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009)

NO-cGMP signalling and cancer therapy
por: Bian, Ka, et al.
Publicado: (2013)

Role of cGMP in fat and metabolism
por: Pfeifer, Alexander, et al.
Publicado: (2013)

cGMP Signaling in Photoreceptor Degeneration
por: Li, Shujuan, et al.
Publicado: (2023)

Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017)

cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
por: Friebe, Andreas, et al.
Publicado: (2019)

Regulation of deactivation of photoreceptor G protein by its target enzyme and cGMP
por: Arshavsky, Vadim Yu., et al.
Publicado: (1992)

Natriuretic Peptides/cGMP/cGMP-Dependent Protein Kinase Cascades Promote Muscle Mitochondrial Biogenesis and Prevent Obesity
por: Miyashita, Kazutoshi, et al.
Publicado: (2009)

Targeting L-arginine-nitric oxide-cGMP pathway in pulmonary arterial hypertension
por: Tang, Haiyang, et al.
Publicado: (2017)

Elevated retinal cGMP is not associated with elevated circulating cGMP levels in a canine model of retinitis pigmentosa
por: Occelli, Laurence M., et al.
Publicado: (2022)

The 10th International Conference on cGMP 2022: recent trends in cGMP research and development—meeting report
por: Friebe, Andreas, et al.
Publicado: (2023)

The ANP/cGMP/cGMP-dependent protein kinase pathway counteracts Angiotensin II-stimulated calcium mobilization in cardiac myocytes
por: Klaiber, Michael, et al.
Publicado: (2009)

The cGMP system in normal and degenerating mouse neuroretina: New proteins with cGMP interaction potential identified by a proteomics approach
por: Rasmussen, Michel, et al.
Publicado: (2020)

Structural and mechanistic insights into cGMP signaling
por: Rauch, Annika, et al.
Publicado: (2009)

Vascular and renal function of cGMP signalling
por: Schlossmann, Jens, et al.
Publicado: (2011)

Role of cGMP/PKG in fat tissue
por: Pfeifer, Alexander
Publicado: (2011)

cGMP becomes a drug target
por: Schlossmann, Jens, et al.
Publicado: (2012)

NO-H(2)S interactions involve cGMP
por: Papapetropoulos, Andreas
Publicado: (2013)

cGMP kinase: past, presence and future
por: Hofmann, Franz, et al.
Publicado: (2013)

Natriuretic peptides and cGMP in metabolic disease
por: Collins, Sheila
Publicado: (2015)

NO-dependent cGMP signalling in neurons and astrocytes
por: Giesen, Jan, et al.
Publicado: (2015)

Modulating cGMP to Treat Lung Diseases
por: Ghofrani, Hossein-Ardeschir, et al.
Publicado: (2009)

Forty-five years of cGMP research in Dictyostelium: understanding the regulation and function of the cGMP pathway for cell movement and chemotaxis
por: van Haastert, Peter J. M., et al.
Publicado: (2021)

Editorial of the Special Issue: cGMP-Signaling in Cells and Tissues: Molecular, Functional and Pharmacological Aspects
por: Schlossmann, Jens
Publicado: (2022)

Identification of novel target proteins of cGMP/cAMP signaling pathway using cGMP/cAMP capture compound mass spectrometry (CCMS)
por: Luo, Yan, et al.
Publicado: (2009)

Extracellular cGMP Modulates Learning Biphasically by Modulating Glycine Receptors, CaMKII and Glutamate-Nitric Oxide-cGMP Pathway
por: Cabrera-Pastor, Andrea, et al.
Publicado: (2016)

cGMP-Dependent Protein Kinase Inhibitors in Health and Disease
por: Wolfertstetter, Stefanie, et al.
Publicado: (2013)

Activation of the cGMP/protein kinase G system in breast cancer by the dopamine receptor-1
por: Ben-Jonathan, Nira, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c202s89ione3q27ojr84rad2nv